What is TB+?

The world is currently facing converging health crises: rising co-infections, increasing antimicrobial resistance (AMR), unstable global environments, and widening inequalities. KNCV’s global reputation in TB programming positions it well to respond to these challenges holistically. Through cross-disease integration, innovative health financing, and by addressing social determinants, including human rights.

The TB+ initiative is an integrated program and strategic construct that expands KNCV’s capabilities beyond tuberculosis to include lung health and other related conditions. It aims to address the broader continuum of health threats while maintaining a strong commitment to ending TB. 

TB+ means leveraging KNCV’s decades of experience, expertise, and tools developed for TB to address other infectious diseases, while also using broader health system investments to strengthen TB care and prevention.